Amgen Inc.Amgen Inc.Amgen Inc.

Amgen Inc.

No trades
No trades

Price target

398.710.000.00%
The 28 analysts offering 1-year price forecasts have a max estimate of — and a min estimate of —.

Analyst rating

Based on 37 analysts giving stock ratings in the past 3 months.

EPS

Reported
Estimate
Metrics
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Metrics
Reported
Estimate
Surprise
Disclaimer

Frequently asked questions


The current price of AMGN is 403.04 USD — it has decreased by −1.04% in the past 24 hours. Watch Amgen Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Amgen Inc. stocks are traded under the ticker AMGN.
AMGN stock has fallen by −1.28% compared to the previous week, the month change is a −8.54% fall, over the last year Amgen Inc. has showed a 35.11% increase.
We've gathered analysts' opinions on Amgen Inc. future price: according to them, AMGN price has a max estimate of 530.00 USD and a min estimate of 225.00 USD. Watch AMGN chart and read a more detailed Amgen Inc. stock forecast: see what analysts think of Amgen Inc. and suggest that you do with its stocks.
AMGN reached its all-time high on Aug 25, 2026 with the price of 447.03 USD, and its all-time low was 0.08 USD and was reached on Nov 19, 1984. View more price dynamics on AMGN chart.
See other stocks reaching their highest and lowest prices.
AMGN stock is 2.04% volatile and has beta coefficient of 0.34. Track Amgen Inc. stock price on the chart and check out the list of the most volatile stocks — is Amgen Inc. there?
Today Amgen Inc. has the market capitalization of ‪217.90 B‬, it has increased by 1.92% over the last week.
Yes, you can track Amgen Inc. financials in yearly and quarterly reports right on TradingView.
Amgen Inc. is going to release the next earnings report on Nov 3, 2026. Keep track of upcoming events with our Earnings Calendar.
AMGN earnings for the last quarter are 6.29 USD per share, whereas the estimation was 5.62 USD resulting in a 11.97% surprise. The estimated earnings for the next quarter are 5.79 USD per share. See more details about Amgen Inc. earnings.
Amgen Inc. revenue for the last quarter amounts to ‪10.05 B‬ USD, despite the estimated figure of ‪9.43 B‬ USD. In the next quarter, revenue is expected to reach ‪10.05 B‬ USD.
AMGN net income for the last quarter is ‪2.38 B‬ USD, while the quarter before that showed ‪1.82 B‬ USD of net income which accounts for 0.00% change. Track more Amgen Inc. financial stats to get the full picture.
Yes, AMGN dividends are paid quarterly. The last dividend per share was 2.52 USD. As of today, Dividend Yield (TTM)% is 2.47%. Tracking Amgen Inc. dividends might help you take more informed decisions.
Amgen Inc. dividend yield was 2.91% in 2025, and payout ratio reached 66.92%. The year before the numbers were 3.45% and 119.05% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Oct 5, 2026, the company has ‪31.5 K‬ employees. See our rating of the largest employees — is Amgen Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Amgen Inc. EBITDA is ‪17.39 B‬ USD, and current EBITDA margin is 43.12%. See more stats in Amgen Inc. financial statements.
Like other stocks, AMGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Amgen Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Amgen Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Amgen Inc. stock shows the buy signal. See more of Amgen Inc. technicals for a more comprehensive analysis.